Background: We believe errors in the risk assessment of acutely ill patients occur because only vital signs without concurrent functional capacity are considered. We, therefore, developed the PARIS risk score based on blood pressure, age, respiratory rate, loss of independence and oxygen saturation. Aim: Validation of the PARIS score in four independent cohorts from three countries. Methods: Retrospective cohort study of acutely ill patients admitted to hospitals in Denmark, Ireland and Uganda. Vital signs and functional capacity (registered as ability to stand or walk or get into bed unaided) was recorded upon arrival. Patients were followed up for 7 days (Denmark and Ireland) or until discharge (Uganda) and mortality recorded. The discriminatory power (ability to identify patients at increased risk) was determined using area under the receiver operating characteristics curve (AUROC) and calibration (precision) using Hosmer-Lemeshow goodness of fit test. Results: Out of 14 447 patients, 327 (2.3%) died within 7 days: median age was 59 (39-75) years and 7458 (51.8%) were female. Seven-day mortality increased from 0.3% with a score of 0-26.7% with a score of 5. The score's AUROC as 0.833 [95% confidence interval (95% CI) 0.811-0.856], 0.817 (95% CI 0.792-0.842) and 0.894 (95% CI 0.813-0.974) for all patients, medical patients and surgical patients, respectively. However, except for surgical patients, calibration of the score was poor. Conclusion: The PARIS score can identify both high and low risk acutely admitted medical and surgical patients, but calibration was poor for medical patients.
Introduction
The accurate identification of high-risk patients has always been a challenge for acute care physicians, 1 and the use of vital sign measurement on arrival to hospital has only limited reliability and validity. 2 We have, therefore, previously argued that mobility or other indicators of functional capacity should also be taken into account. [3] [4] [5] The PARIS score includes blood pressure, age, respiratory rate, loss of independence (a marker for functional capacity) and oxygen saturation. It predicts 7-day mortality in acutely ill medical patients who are admitted to hospital and has been validated in three independent medical cohorts in Denmark. 6 In this study, we report the PARIS score's ability to predict mortality in four additional independent cohorts of patients from completely different clinical settings treated in different health care systems in three different countries.
Methods
This is a retrospective cohort study of four independent patient cohorts from four hospitals in three different countries. The study report complies with the TRIPOD guidelines. 7 
Patients
Only acutely ill adult patients admitted to hospital from emergency departments (EDs), or medical or surgical admission units were included in the study. For patients with multiple admissions during the study period, only the first admission during the study period was examined.
Settings
We included patients from the following four units:
1. The Hospital of South West Jutland (where the PARIS score was originally developed) is a 450-bed regional teaching hospital with all medical specialties, general and orthopedic surgery, gynecology and pediatrics on site and an intensive care unit. The study included patients admitted to the hospital's surgical admission unit from 24 April 2013 until 9 December 2013. 2. Lillebaelt Hospital, Kolding, is a 320-bed Danish regional teaching hospital. Although smaller, this hospital is comparable to the Hospital of South West Jutland. The study included gynecology, general surgery, vascular surgery and medical patients admitted to hospital through its admission unit from 1 January 2010 till 30 June 2010. 3. Nenagh Hospital is a small community hospital in Ireland. 4 The PARIS score was retrospectively calculated on all acutely admitted medical patients from 1 February 1999 till 31 January 2004. 4. Kitovu Hospital is a missionary hospital in Masaka, Uganda. 8 The study included all acutely admitted medical patients from 22 July 2011 till 22 September 2012.
Data collection
All data were recorded on clinical indication and not prespecified by protocol. Loss of independence, i.e. inability to stand or walk unaided, was the only variable not recorded as standard. At the Hospital of South West Jutland, Nenagh Hospital and Kitovu Hospital, nurses were instructed to record if the patient was able to get onto the bed unaided (e.g. from a chair, wheelchair or ambulance gurney etc.). At Lillebaelt Hospital, a single study nurse, with guidance from the principal investigator, extracted data on loss of independence retrospectively from the electronic records. Doubtful cases were resolved by consensus. Inter-observer reliability was not assessed in any of the study settings.
Score
The PARIS score assigns 1 point for each of: (i) systolic blood pressure 115 mmHg, (ii) age 80 years, (iii) respiratory rate 22 breaths per minute, (iv) loss of independence or (v) peripheral oxygen saturation 93% or use of supplementary oxygen. 6 
Follow-up
Follow-up on Danish patients was completed through the Danish Civil Register 9 ensuring complete follow-up. Follow-up of Irish patients was completed by personally contacting all patients who had not re-attended the health service within 1 year of discharge and whose death had not been registered 4 while Ugandan patients only had in-hospital follow-up. 10 
Ethics
Under Danish law, retrospective registry studies do not require approval by an ethics committee. 11 The study was approved by the Danish Authorities for Health and Medicines and the Danish Data Protection Agency. Use of data from the Irish and Ugandan cohorts was approved by the respective ethics committees.
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Statistics
Data are presented as medians (interquartile ranges) or proportions [95% confidence interval (95% CI)]. The discriminatory power (i.e. the extent to which the model will assign a higher score to a patient with an outcome than a patient without an outcome) was presented as area under the receiver operating characteristics curve with no other variables included as confounders. An area under the curve of >0.8 indicates good discriminatory power. 12 Calibration, i.e. the ability of the model to accurately indicate the magnitude of risk for a given subject, was assessed using the Hosmer-Lemeshow goodness of fit test and was calculated according to Seymour et al. 13 For calibration to be acceptable, the P values must be > 0.05. As an alternative to Hosmer-Lemeshow, we also calculated the Brier score, where a value as close to 0 as possible is preferable. In case of missing data, the patient was excluded from analysis. Patients were stratified according to the specialty they were assigned to on presentation. Sensitivity analysis was performed by assuming missing data was normal (e.g. if respiratory rate was not known it was assumed to score zero and not added to the PARIS score). Stata 14.1 was used for analyses (Stata Corp LP, College Station, TX, USA).
Results
We included 14 447 patients (age 18 or older), 3487 Discriminatory power for all patients (n ¼ 11 366) was 0.833 (0.811-0.856) and calibration P ¼ 0.00 (Table 2 and Figure 1) . The overall Brier test showed acceptable performance at 0.0216. For medical patients (n ¼ 9021), discriminatory power was 0.817 (0.792-0.842) and calibration P ¼ 0.02. For non-medical patients (n ¼ 2345), discriminatory power was 0.894 (0.813-0.974) and calibration P ¼ 0.25. Seven-day mortality increased from 0.3% with a score 0 to 26.7% for a score 5 ( Figure 2 and Table 3) .
If all missing data were assumed to be normal, the discriminatory power for medical patients (n ¼ 9785) was 0.790 (0.763-0.816) and calibration P ¼ 0.34. For non-medical patients (n ¼ 4662), the discriminatory power was 0.859 (0.801-0.917) but the calibration poor, P ¼ 0.02. 
Data are presented as number (%) or median (interquartile range). Discrimination plots Figure 1 . Discrimination plots for 7-day all-cause mortality for selected patient groups from all origins. The ROC value represents the area under the receiving operating characteristics curve for each group of patients; n, the number of patients in each group. 
Discussion
This study shows that a simple risk stratification score which is easy to remember and calculate performs reasonably well in both medical and surgical patients from four hospitals in three countries. In all four cohorts, it had a good to excellent ability to identify high-risk patients (i.e. good discriminatory power). However, its precision (i.e. calibration) was suboptimal in several of the settings. Surprisingly, even though the model was originally developed for medical patients, the highest discrimination was in surgical patients and lowest in medical patients in Uganda.
In our initial report of the PARIS score, patients with a score of 1 or less had a low mortality (i.e. <1.0%). 6 In the present study, the 7 day mortality of non-medical patients with a score of 1 or less was <0.8%, while medical patients with a score of 0 and 1 had a mortality of 0.4% and 2.1%, respectively. We thus can regard patients with a PARIS score of 0 as been at very low risk regardless of reason for admission. All patients with a score of 3, regardless of specialty, had a mortality >12%. Surprisingly, the score performed well in non-medical patients, and in some instances even better than in medical patients. The relatively poor performance of the PARIS in medical patients from sub-Saharan Africa might be explained by the different case-mix of these patients compared to the other three cohorts, and that many sick patients would have been unable to afford remaining in the hospital and/or chosen to die at home. However, even in Ugandan patients the performance of this easy to remember and calculate score was comparable to many more complex predictive models used in the developed world.
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The main question, of cause, is what does the PARIS score add to everyday clinical practice? Most existing risk stratification tools only incorporate vital signs. PARIS also includes a variable for physical performance, i.e. mobility. We believe that this enhances the performance significantly and helps improve identification of at-risk patients. In a recently published article, we have shown that adding a marker for physical performance improved a common early warning score substantially. 15 The diverse nature of our patients, both in regard to time of inclusion, geography, but also hospital systems and specialties represent a strength in our article. We believe a human being is a human being and that physiology does not change regardless of continent or date of admission to hospital. Of cause, treatment continuously improve and systems get updated, but the basic response to deterioration remains unchanged. Our common physiology reponds to stimuli more of less in the same way.
This study has several limitations. While addressed above as a strength, the patients were included over a long time. During this time, treatments changed and systems updated. This could have affected our results. There was no follow-up of Ugandan patients after hospital discharge. The study was a retrospective extraction of data from multiple sources, which included with a score of 5. In the original development cohort, mortality increased from 0.3% with a score of 0, 0.7% with a score of 1-33% with a score of 5. 
Conclusion
The PARIS score can identify both high and low risk acutely ill medical and non-medical patients with acceptable to excellent discriminatory power but calibration (precision) in medical patients and acceptable in surgical.
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